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PENI L AI AN H ASI LAN RA WATA N PRO G RA M  M ETH ADO NE 
DAN TI N JAUA N K ESEDA RAN TE NTA NG  PENY AL AH G UNAAN 
DAD AH  DI  PEN A NG ,  M ALAYSI A  
 
ABSTRAK 
 
Ada yang berpendapat bahawa pengetahuan boleh mempengaruhi penyalahgunaan dadah 
disamping faktor kedua seperti sosioekonomi yang rendah. Terdapat penyelidikan yang 
melaporkan pengetahuan yang rendah tentang penagihan walaupun dikalangan 
masyarakat yang mempunyai penagih yang ramai. Satu kajian deskriptif secara bersilang 
telah di lakukan di Pulau Pinang, Malaysia, untuk mendapatkan maklumat tentang 
keberkesanan secara terapeutik terhadap rawatan penagihan di tiga klinik yang berdaftar 
untuk menjalankan rawatan dengan methadone. Satu lagi kajian dilakukan untuk menilai 
tahap pengetahuan di kawasan yang mempunyai kadar penagih yang ramai (Sg. 
Cheenam), dikalangan pelajar Universiti dan terhadap kumpulan penagih yang 
memerlukan rawatan secara pesakit luar (out-patients of Methadone Maintenance 
Treatment (MMT)). Soalan kajian telah dihasilkan untuk mengumpul maklumat terhadap 
tiga sampel populasi yang dikaji terhadap pengetahuan dan pengurusan praktis pengamal 
rawatan methadone di klinik tersebut. Teknik persampelan secara strafikasi telah 
digunakan untuk mengumpul data dari Kampung Sg.Cheenam, teknik persampelan 
secara mudah digunakan dikalangan pelajar universiti sementara kesemua data dari 
pesakit luar dalam program MMT telah digunapakai dalam kajian tersebut. Data yang 
diperolehi telah dianalisa secara statistik dengan menggunakan ujian stastitik yang sesuai. 
Sejumlah 175 penduduk dari kampong, 180 pelajar dan 283 Pesakit Luar di klinik MMT 
telah dikaji tentang pengetahuan tentang penyalahgunaan dadah dan ciri-cirinya. Tujuh 
perpuluhan tiga peratus(7.3%) di kampong , 20.7% dikalangan pelajar dan 35.1% 
dikalangan pesakit luar menyatakan mereka masih aktif mengambil dadah. Majoriti dari 
mereka ini mengalami pengalaman pertama mengambil dadah pada usia 19-25 tahun. 
Heroin merupakan dadah yang paling kerap digunakan serta kaedah suntikan merupakan 
  xxi 
 
kaedah yang sering digunakan. Purata nilai untuk pengetahuan ialah  21.3 untuk 
penduduk kampong, 28.1 dikalangan pelajar universiti dan 21.9 dari klinik MMT. Tidak 
terdapat sebarang perbezaan statistic diantara pesakit di klinik MMT dengan penduduk 
kampong namun terdapat perbezaan yang signifikan diantara pelajar universiti dengan 
dua kumpulan yang lain. Sebanyak tiga klinik rawatan methadone di Pulau Pinang telah 
dinilai dalam kajian ini. Didapati lebih dari 70% dos yang diberikan  adalah tidak 
konsisten dengan protokol rawatan yang telah disarankan di peringkat nasional. Tujuh 
puluh lapan peratus(78%) dari pesakit luar ini mengalami jangkitan secara kronik. 
Sembilan puluh lapan peratus (98%) dari mereka mengalami virus Hepatitis C. Tidak 
terdapat seorang pun di antara mereka yang mendapat sebarang rawatan terhadap 
penyakit berjangkit tersebut. Kajian ini juga menunjukkan hanya 3.7% dari jumlah 
pesakit luar ini merasakan peningkatan kualiti kehidupan setelah mendapat rawatan 
dengan methadone. Sejumlah 23.7% kes enggan mendapatkan rawatan dilaporkan dari 
Jan 2007- Mei 2008. Sebagai rumusan terdapat jurang perbezaan pengetahuan yang besar 
dikalangan penduduk kampong dan pesakit luar dalam program MMT. Program 
pendidikan adalah diperlukan untuk meningkatkan kesedaran tentang penagihan dan 
penyalahgunaan dadah. Pengurusan dan rawatan di dapati tidak konsisten dengan 
protokol yang telah diberikan. Oleh yang demikian latihan untuk mereka yang 
mempreskripkan rawatan methadone ini adalah diperlukan. Adalah disarankan agar 
garispanduan diperingkat nasional dapat di perkemaskan berdasarkan pengurusan dan 
rawatan yang telah dibuktikan. 
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EVA LUA TI O N O F TRE AT M ENT O UTCO M ES O F M ETH ADO NE 
PRO G RA M  AND K NO WLEDG E A WARE N ESS SU R VEY O N 
DRUG  A BUSE I N  PENA N G ,  M ALAYSI A  
 
ABSTRACT 
 
A cross-sectional descriptive survey was conducted in Pulau Pinang, Malaysia, to provide 
the information regarding to the therapeutic effectiveness in the management and 
treatment of Addiction in three registered methadone clinics of Pinang state. Subsequent 
study was carried out to determine the level of knowledge in high prevalence area (Sg. 
Cheenam), among university students (USM) and treatment seeking group of addicts 
(out-patients of Methadone Maintenance Treatment (MMT)). Self administered 
questionnaires were developed to collect the required information from above three 
sample population knowledge and management practices of practitioners in methadone 
clinics. Stratified random sampling technique was used to collect data from Sg.Cheenam 
village, convenience sampling technique was employed to collect university sample 
while all the active out-patients on MMT were included in the survey. Data was analyzed 
statistically by applying appropriate statistical tests. A total of 175 persons from village, 
180 students and 283 out-patients of MMT were surveyed for their knowledge about drug 
abuse and characteristics. Seven percent (7.3%) participants from village, 20.7% of 
students and 35.1% out-patients claimed they were active in drug-taking activities. 
Majority of addicts in three groups, experienced first drug abuse at the age of 19-25 
years. Heroin was still the drug of choice found in the survey, intravenous injection was 
the pronounced route of administration. The overall mean scores of knowledge was 21.3 
for villagers, 28.1 for university students and 21.9 for MMT patients. There was no 
significant difference found between the MMT patients and villagers groups while the 
university student group was found to be significantly higher when compared with the 
other two groups. Three methadone management therapy clinics of Pinang state were 
surveyed in the study. It was found that more then 70% dose setting were inconsistent 
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with the national protocol. Seventy-eight percent (78%) of out-patients experienced 
chronic infection. Ninety-eight percent (98%) of them were confirmed to Hepatitis C 
virus. No single person was found on supportive therapy for chronic infection. Data 
showed that only 3.7% of total out-patients showed improvement in their quality of 
health after taking methadone treatment. A total of 23.7% drop-out cases were found 
during (Jan 2007- May 2008) survey. It is concluded that there is a sizable gap of lack of 
knowledge found among the village and out-patients of MMT. Educational programs are 
required for people, to increase their awareness about the addiction and drug abuse. 
Management and treatment practices are quiet inconsistent to protocol, so there is a need 
to increase the methadone prescribing trainings for practitioners. Strong 
recommendations are made for the update of national guideline on evidence – based 
management and treatment setting.   
 1 
    CHAPTER ONE 
           INTRODUCTION 
 
1.1 Background 
 
Drug is a word derived in the era of fourteenth-century by French word drogue, mean to 
recognize as a ‘dry substance’. Almost all pharmaceuticals at that era were involved in 
drug conversion from dried herbs (Palfai and Jankiewicz, 1991), even though, there is no 
satisfying way of delineating that, what is & what is not a drug – e.g., the difference 
between water, vitamin supplements and penicillin (Goode, 1998). Some of them feel 
that, it is appropriate to refer a “chemical or substance abuse”, indistinctness in the use of 
the term drug has lead some serious social consequences. 
 
In the contemporary society the word drug has often two connotations – one is positive, 
that explains its crucial role in medicines, while other is negative, reflecting synthetic 
makeup of these chemicals & also the self-destruction and socially venomous pattern of 
misuse (Jones, Shainberg and Byer, 1979). A drug in further detailed discussion mostly 
refers as substances having mood-altering, psychotropic (or psychoactive) effects. This 
definition also includes caffeine, nicotine, alcohol and as well as illegal chemicals such as 
marijuana and heroin (Goode, 1989). 
 
 
 
 2 
1.2 Definitions and Statements 
 
1.2.1 Drug abuse 
World Health Organization (1969) defines “Abuse” (drug, alcohol, chemical, substance, 
or psychoactive substance) as a group of terms in wide use but of variety of meanings. It 
may also define as persistent or sporadic excessive drug use contradictory with or 
unrelated to acceptable in medical practices. Narcotic is usually refers to opiates or 
opioids, which are often called as narcotic analgesic. It is used imprecisely to mean of 
illicit drugs. Abuse is mostly referred to non-medical or unsanctioned patterns of use, 
irrespective of consequences. WHO expert committee on drug dependence defines drug 
abuse as term of, a chemical agent that induces stupor, coma, or insensibility to pain. 
 
Drug abuse may also be defined in a number of perspectives: The legal definition equates 
drug use with that of the meager act of using a proscribed drug or/and using a drug under 
proscribed conditions. The moral definition is similar, but more emphasis is given on the 
motivation or purpose for which the drug is used. The medical model opposes unusual 
précised usage but emphasize on the physical and mental consequences for the users, 
whilst the social definition stresses on social responsibility and adverse effect on others 
subjected in the community (Balter, 1974). 
 
Drug abuse and related crime permeate into the every corner of society, afflicting the 
inner cities, prosperous borders & rural communities. Drug affects the rich and poor, 
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educated & uneducated, professional & proletarian workers also young & old (Office of 
National Drug Control Policy, 2001). 
 
American Social Health Association (1972) defines drug abuse as use of mood altering 
chemicals outside of medical supervisions and in a manner which is harmful to the person 
and the community. Other definition, such as those are referred with World Health 
Organization and American Medical Association, includes the term of physical and/or 
psychological dependency (Zinberg, 1984). 
 
Numerous definitions of drug abuse that reflect social values, not scientific insight: “One 
reason for the prevalence of definitions to drug abuse that are neither logical nor 
scientific is the strength of Pure Moralism in American culture which frowns on the 
pressure and recreation provided by intoxicants” (Zinberg, 1984). 
 
The American Psychiatric Association (1994:182) refers to substance abuse as a 
“maladaptive pattern of substance use manifested by recurrent and significant adverse 
consequences related to the repeated use of substances, including repeated failure to 
fulfill major role obligations, repeated use in situation in which it is physically hazardous, 
multiple legal problems and recurrent social and interpersonal problems. 
 
Drug abuse implies the misuse of certain substances – its a moral not a scientific. 
Sometimes term as: an unstandardized, value-laden and highly relative, generally 
implying to drugs use that are excessive, dangerous or undesirable to the individual or 
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community (Nelson et al., 1982). Drug abuse implies willful, improper use due to an 
underlying disorder or a quest for riotous or immoral pleasure (N. Miller, 1995). 
 
1.2.2 Addiction 
Addiction is derived from the Latin verb that is addicere; means to bind a person with 
one thing or another. 
Drug addiction is defined as to lost control over drug taking, even in the face of adverse 
physical, personal, or severe social consequences (Society for Neuroscience, 2002). 
Norman Miller (1995) avoids using the term of drug abuse and opts, instead to 
characterized addiction by: 
1. Stage I: Preoccupation, the addicts are assigned to a high priority to acquiring 
drugs. Social relationships and employment are jeopardized in the quest for drugs 
and the consequences of use. 
2. Stage II: Compulsion, the addicts are continued to use drugs despite serious 
adverse consequences. He or she will often deny the connection between the 
adverse consequences and the use of drugs. 
3. Stage III: Relapse, In the face of adverse consequences, addicts are discontinuing 
drugs but subsequently return to the abnormal use. 
Dennis Donovan (1988) perceives addiction as a complex, progressive behavior pattern 
having biological, psychological, sociological components. What sets this behavior apart 
from others is the individual’s devastatingly pathological involvement in/or attachment to 
it, subjective compulsion to use it & shows reduce ability to exert personal control over 
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it. The behavior pattern continues despite it leads to many negative impacts on the 
physical, psychological and social functioning of the individual. 
 
In dominant view, addiction is predominately defined as; the preoccupation with the use 
of psychoactive substances, characterized by neurochemical and molecular changes in the 
brain. 
 
1.2.3 Response Determining Definitions 
It is found that varieties of lawful substances are addictive in nature and have been 
abused widely among “respectable community”. Social expectations and definitions 
determine what kind of drug-taking is appropriate and the social situations that are 
approved or disapproved for drug use. It is acceptable concept that the use of drug is 
neither inherently bad nor inherently good – it is among the socially determined values 
(Goode, 1989). Thus Mormons and Christian considers that the use of tea and coffee is 
“abusive”, while Muslims and some Protestant denominations have the same view of 
alcohol, although they permit tobacco for smoking (Goode, 1989).  
 
The National Commission on Marijuana and Drug Abuse (1973) argued that the word 
drug abuse must be removed from official pronouncements and public policy dialogue 
because the term has no functional integrity and has become no more than an arbitrary 
codeword for that drug use which is now considered as wrong. Some literature showed 
that moderate use of a drug will be termed as “abuse” or it will be socially acceptable and 
lawful – if society term to determine so, regardless to the relative danger inherent in the 
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substance. In other words: How society defines drug abuse reflects how society responds 
to drug use. 
 
1.2.4 Pattern pathway of drug abuse 
The use of psychoactive chemicals, both licit and illicit, can be labeled as drug abuse 
only when the user becomes dysfunctional for a consequences; for example, unable to 
maintain employment; impaired social relationships; exhibits dangerous – reckless or 
aggressive behavior and/or significantly endangers his or her health. Thus drug use, as 
opposed to drug abuse can be viewed in continuum (Figure 1.1). 
At the one end of the continuum there is the nonuser who has never used prohibited or 
abused lawful psychoactive drugs. Along the continuum is experimental use and 
culturally endorsed use, which includes the use of drugs – wines or peyotes, for example, 
in religious ceremonies. It is mean that regardless of the duration of use, such people tend 
not to escalate their use to uncontrollable amounts (for the story of recreational heroin 
user who was not dysfunctional) observed in Marlowe (1999).  
In demonstrating the case, long term cocaine users have found that recreational pattern 
can be maintained for a decade or more without loss of control. Such use tends to occur 
in weekly or biweekly episodes and user perceives that the effects facilitate social 
functioning (Siegel, 1989). 
At the far end of the continuum is the drug dependent or compulsive user whose life often 
revolves around obtaining, maintaining and using a supply of drugs. For the compulsive 
user, failure to ingest an adequate supply of the desired drug results in psychological 
stress and discomfort and there may also be physical withdrawal symptoms. 
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Naturally these data sources provide a highly selected sample of users: those who have 
encountered significant personal, medical, social, or legal problems in conjunction with 
their drug use, and thus represent the pathological end of the using spectrum (Zinberg et 
al., 1978). 
 
 
 
 
 
 
      
         
         Figure 1.1 Drug continuum 
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1.3 Opiates 
 
In the end of 18th century (Latimer and Goldberg, 1981) or in the early of 19th (Merlin, 
1984; Nelson et al., 1982), German pharmacist poured a liquid ammonia over opium and 
obtained an alkaloid, a white crystalline powder that he found to be many time more 
powerful than opium. Frederich W. Serturner named the alkaloid morphium, the Greek 
god of sleep and dreams. Ten parts of opium can be refined into one part of morphine 
(Bresler, 1980). 
 
By the 1850’s morphine tablet and different varieties of morphine was made available in 
the market without prescription (Latimer., Goldberg, 1981). In 1856 the hypodermic 
method of injecting morphine directly into the blood stream was introduced. The 
popularity of morphine markly increased during the civil war when the intravenous use of 
the drug to treat battlefield casualties, which later was found to be rather indiscriminate 
(Terry., Pellens, 1982). Anyone who visited nearly any physician for any complaint of 
toothache would be prescribed morphine as a treatment (Latimer., Goldberg, 1981), and 
thus the substance was widely abused by the physicians themselves. Morphine abused in 
the latter part of the 19th century was apparently widespread in rural America (Terry., 
Pellens, 1982). 
 
In the start of 1870’s, doctors injected women with morphine to numb the pain of “female 
troubles”. By the 1890’s, when the drug epidemic peaked, female medical addicts made 
up almost half of all addicts in United States. In the 20th century, the drug scene shifted to 
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underworld element of urban areas of America, the disreputable “sporting class”: 
prostitutes, pimps, thieves, gamblers, gangsters, entertainers, active homosexuals, and 
youth who admired the sporting men and women (Stearns, 1998). 
 
In early 1987, a British chemist experimenting with morphine to synthesize the 
diacetylmorphine, and thus the most powerful of opiates came into being. In 1898 
commercial promotion was done when the highly respected German pharmaceutical 
combine Bayer, in perfectly good faith but perhaps without sufficient prior care. They 
coined the trade name ‘heroin’ and which they marketed as a “sedative for coughs” 
(Bresler, 1980). Jack Nelson and his colleagues (1982) stated that the heroin was actually 
isolated in 1898 in Germany by Heinrich Dreser, who was searching for a non habit-
forming pain reliever to take the place of morphine. Dresser named it after the German 
word heroisch, means large and powerful. Figure 1.2 shows the century distribution of 
the drugs / substance related to history of development and war against the anti drug 
social terminology. 
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      1. German pharmacist discovers morphine.  
      2. First opium war takes place. 
      3. Anti-immigrant know-nothing party formed. 
      4. Cocaine isolated from coca leaf. 
      5. One-third of United States have prohibition laws. 
      6. Second opium war done. 
      7. Morphine is widely used in the civil war. 
      8. Heroin discovered. 
      9. Sigmund Freud begins using cocaine. 
      10. Late 18th, amphetamine was synthesized 1st time. 
      11. End 18th, anti-saloon league was organized & 
             launches a political action campaign.  
      
 
       
     1. Drug regulation get started in Pure Food and Drug Act. 
     2. First international opium conference held in Shanghai. 
     3. Second international opium conference. The Hague;  
         barbiturates are introduced & widespread use. 
     4. Passage of Harrison act bring narcotics under jurisdiction. 
     5. World War I; widespread use of alcohol & morphine. 
     6. Narcotics clinics opened in major cities of United States. 
     7. Prohibition 18th Amendment adopted in favor of physicians 
            used morphine in the maintenance doses of the addicts. 
     8. Federal narcotic agents close down the narcotic clinics. 
     9. United States rule that physicians can prescribe small dose 
         heroin for the treatment of addicts. 
     10. media campaign on marijuana use; amphetamine spread.. 
     11. World War II; cause drug epidemic as soldier returned. 
     12. In Korean War; amphetamine is spread among soldiers. 
     13. Attitude towards recreational drug use change; LSD  
           become popular; medical profession focus on treatment; 
           including the use of methadone. 
     14. California established a civil commitment program. 
     15. Drug Enforcement Administration (DEA) established. 
     16. Cocaine popular; smokable form of amphetamine appear. 
     17. Office of national drug control strategy was established. 
      
         
1800’s 
Century Era    History Distribution 
 
  1900’s 
In the late 1990’s a 
period was began 
that was notable 
for a lack of 
political interest in 
drug abuse. 
21st century: club drugs as ecstasy become popular in dance clubs & the issue of medical 
marijuana pits states that permit it against the federal government, which does not; the 
problem of binge drinking among college youth gains widespread attention. 
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Fig 1.2 Descriptive history of substance abuse in the human civilization 
1.3 Risk factors and Social theory 
 
The social or behavioral sciences have to study the etiology of drug addiction in a more 
circuitous manner. Sociological theory is concerned with social structures and social 
behavior, so it examines drug use in its social context. A sociological perspective often 
views drug use as the product of social conditions and relationship that cause despair, 
frustration, hopelessness and general feelings of alienation in the most disadvantaged 
segments of the population (Biernacki, 1986).  
 
The National Institute on Drug Abuse (Drug Abuse, 1987) outlined factors that are 
associated positively with adolescent substance abuse, factors found more frequently in 
deprived socioeconomic environments: 
 
1. Families whose members have a history of alcohol abuse and/or histories of 
antisocial behavior or criminality. 
2. Inconsistent parental supervision, with reactions that swing from permissiveness 
to severity. 
3. Parental approval or use of dangerous substances. 
4. Friends who abuse drugs. 
5. Children who fail in school during late elementary years and who show a lack of 
interest in school during early adolescence. 
6. Children who are alienated and rebellious. 
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7. Antisocial behavior during early adolescence, particularly aggressive behavior. 
Many sociological studies have found that drug use among adolescents is motivated by 
intermittent feelings of boredom and depression, like wise other aspects of adolescence, it 
is typically upon reaching adulthood. Table 1.1 showed various factors that are 
influenced to drug abuse in the common society. Furthermore, contrary to conventional 
wisdom, research has found that drug use is typically a group activity of socially well-
integrated youngsters (Glassner., et al., 1989). That is, contrary to some psychological 
views, the adolescent drug user is socially competent (or ego sufficient). Sociological 
studies often challenge the conflicting views of the adolescent drug user as either a 
deviate isolate or peer-driven conformist. Sociology also cautions us to separate drug use 
that is situational and transitional from drug dependence or addiction, which is 
compulsive and dysfunctional. 
 
In England, the much smaller number of those adolescents who use illicit drugs regularly, 
as opposed to those who have tried illicit drugs, reminds us that because a young person 
has tried an illicit drug does not mean that they will necessarily develop a pattern of long 
term misuse (Advisory council on the Misuse of Drugs, 1998). 
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Table 1.1 Risk factors result to Drug Abuse (Source: Newcomb (1995: 17) 
1. Culture and society: 
 
• Laws favorable to drug use 
• Social norms favorable to drug use 
• Availability of drugs in streets. 
• Extreme economic deprivations  
• Neighborhood disorganization 
 
2. Interpersonal  
 
• Parent and family drug use 
• Positive family attitude towards drug use 
• Poor/inconsistent family management practices 
• Family conflict and disruption 
• Peer rejection 
• Association with drug-using peers 
 
3. Psycho behavioral  
 
• Early/persistent problem behavior 
• Academic failure 
• Low commitment to school 
• Alienation 
• Rebelliousness 
• Favorable attitude towards drug use 
• Early onset of drug use 
 
4. Biogenetic 
 
• Inherited susceptible to drug abuse 
• Psycho physiological vulnerability to drug effects. 
 
 
 
 
 
 
 14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart 1.0 Clinical withdrawal sign & symptoms of opioid addiction 
Source: Ginzburg, 1986 
 
1.5 Epidemiological Conforming data on drug abuse 
 
Both tobacco and alcohol share a role as ‘gateway drugs’ that presage use of other 
psychoactive drugs; in other words, alcohol and/or tobacco use precedes most subsequent 
use of marijuana and cocaine (Shiffman. Saul and Mark.  Balabnis, 1995), thus “there is a 
fairly consistent progression of adolescent substance use beginning with the licit drug 
alcohol and/or cigarettes, moving on to illicit substances initiating with marijuana and 
Sign and Symptoms of Opioid Withdrawal state: 
Several 
hours after 
last use 
After 8-15 
hours 
After 16-
24 hours. 
 
• Anxiety 
• Restlessness 
• Irritability 
• Drug craving 
 
• Yawning 
 
• perspiration 
 
• Sneezing 
• Sniffles 
• Anorexia (severe 
appetite loss) 
• Vomiting 
• Abdominal cramps 
• Bone pains 
• Tremors 
• Weakness 
• Insomnia 
• Goose flesh 
• Convulsion (very rare) 
• Cardiovascular collapse 
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progressing to cocaine and ‘harder’, more problematic drugs” (Johnson. P., Boles., 
Kleber, 2000). 
 
Each day, more than 3,000 young persons smoke their first cigarette and the likelihood of 
becoming addicted to nicotine is higher for these young smokers than for those who 
begin later in life (Zickler, 2002). Nearly one in four high school seniors’ smoke every 
day and more than one in eight smokes a half-pack or more each day. Young people of 
age between twelve to seventeen years who smoke are about twelve times more likely to 
use illegal drugs and sixteen times more likely to drink heavily than youths who did not 
smoke. Alcohol use among the young adults strongly correlates with adult drug use latter 
in term of long dependence. For example, adults who started drinking at early ages are 
nearly eight times more likely to use cocaine than adults who did not drink as children 
(Office of National Drug Control policy, 2000). 
 
1.5.1 Global informatory data on drug abuse 
Next to traffic accidents, narcotic addiction today is the greatest single cause of death in 
the age group between 18-35 years (Birgitte Kringsholm, 1981).There is global increase 
in the production, transportation and consumption of opioid drugs. It is estimated that 
worldwide there are about 185 million drug abusers (UNDCP, 2002) Table: 1.2. Among 
them 13.5 million people take opioid, including 9.2 million are heroin users (those from 
Europe). In America, the non-medically use of narcotic drugs increased from 1.9 million 
to 3.1 million persons in between the year 2002 to 2004 (Office of Applied studies, 
2005). 
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Table: 1.2 Global estimates for the drug abuse 
No’s SUBSTANCE OF ABUSE Figure Source of the data 
01 Illicit drugs 185 million illicit drug abusers UNDCP, 2002 
02 Alcohol 2 billion alcohol users WHO, 2002 
03 Tobacco 1.3 billion smokers WHO, 2002 
 
Table 1.3 describes the age and related ratio of drug in year 2003 (NSDUH, 2003). The 
percentage ratio of drug abuse between male and female in 2003 is 12.2% and 6.2%. It 
was seemed double in male as compared to females. However the drug abuse in 2002 by 
the age of 12 – 17 years was about 11.6% and there was no significant change in this 
figure in year 2003 that was about 11.2%.  
 
But the cumulative drug abuse by male and female in between the age of 12 -17 years 
was 8.7% and 9.1%. The results showed that the prevalence of drug abuse was more in 
female teenagers as to that of male teenagers in America. 
Table: 1.3 Statistical data correlates with the age 
  Statistical data of drug abuse in relation with age (2003) 
Age range Statistical percentage  
12 – 13 years 3.8% 
14 – 15 years 10.9% 
16 – 17 years 19.2% 
18 – 20 years 23.3 % (maximum) 
> 20 years Decline in %  
 
Vietnam is also on the highest risks of the global facts; according to the report Vietnam 
has high values on drug abuse cases (Figure 1.3). According to the official figures, the 
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numbers increased from 101,036 users to 170,400 users in between 2000 – 2004 
(UNODC, 2004). 
 
 
 
            
                   
    
  
 
 
 
 
 
Figure 1.3: Official figures on Drug users (2000-2004) 
 
 
 
 
  
  
 
 
 
Figure 1.4: Number of cases discovered in Vietnam 
 
Lifetime prevalence of heroin was seemed to be increasing in Canada. It was about 2.8% 
among the Ontario school students in 1999 as compared to that of 1.9 % in 1998, Canada 
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reported that there is some increase in heroin abuse in 2000 questioners (E. M. Adlaf, 
2000). Prevalence of heroin smoking being particularly high among students in Latvia 
and Romania (7-8 per cent) and Croatia, Italy, Lithuania, Poland and the Russian 
Federation (4-5 per cent). Injecting heroin use was far less commonly reported (Hibell. 
B., 2000). 
 
In India, the Islamic Republic of Iran and Pakistan, large opiate-abusing populations 
exist. Estimates vary considerably for the size of the total heroin abusing populations in 
those countries, with some figures suggesting extremely high male prevalence rates. A 
1996 survey in India estimated that there were between 0.5 and 0.6 million drug-
dependent individuals and that the drug-abusing population could be in the order of 3 
million. A recent assessment exercise in Pakistan highlighted a serious heroin problem 
and estimated the number of chronic male addicts at around half a million (World Drug 
Report, 2006). That study also suggested that drug injection had now become a serious 
problem in the country, with around 15 per cent of heroin addicts regularly using that 
mode of administration. This contrasts with the situation in the mid-1990s where this 
mode of use was negligible. Good prevalence data are not available for Bangladesh, but 
rapid assessment studies carried out in 1996 suggested that the country had a significant 
heroin problem. In China, situation showed that out of 450 million drug and alcohol users 
about 25 million were close to opium users. The estimated number of opiate users in Asia 
is about 8.5 million (World Drug Report, 2006). 
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Globally about 71% of the world drug abusers are opiate abusers and among them 16 
million are heroin abusers. Annual prevalence of opiate abuse in Asia is highest among 
all the data regional resources (Figure 1.5 and Table 1.4) (UNODC, 2006). Studies 
showed that 65% of opium abusers are in Asia (World Drug Report, 2006) (Figure 1.6). 
  
  
 
 
 
 
 
 
Figure 1.5: Regional breakdown of opiates abusers (UNODC, 2006) 
 
Table 1.4: Annual prevalence of opiate abuse, 2003-2005 
Countries              Abuse of opiates                Abuse of heroin 
 No of abusers In% of population 
 15-64 years 
No of abusers In % of population 
of  15-64 years 
Europe 4,030,000 0.7% 3,340,000 0.6% 
Americas 2,280,000 0.4% 1,540,000 0.3% 
Asia 8,530,000 0.3% 5,430,000 0.2% 
Africa    910,000 0.2%     910,000 0.2% 
Source: UNODC, 2006 
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Figure: 1.6 Percentage of drug abuse in Asia 
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Total world population 
6,389 million (100%)  
Population below 15 year and above 64 
years 2,287 million (35.8%) 
Population between 15-64 years 
4,102 million (64.2%) 
Non-drug using population age 15-
64 years 3,902 million (95.1%) 
Annual prevalence of Drug use 200 
million people (4.9%) 
Monthly prevalence of drug abuse 
110 million people (2.7%) 
Weekly prevalence of drug abuse 
65 million people (1.6%) 
Problem drug abuse age 15-64 
years 25 million people (0.6%) 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart 1.1: ILLEGAL DRUG USE AT GLOBAL LEVEL (2004) 
   (In population of age 15-64 years) 
 
Source: WDR (World Drug Report) 2006 
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1 .5 .2  M alays i an  Ep i de m i o log i c a l  da t a  on  dr ug  abus e  
 
The global epidemic of opiate use continue to spread and it causes an increasing burden 
to both developed and under developing countries (Ali, R., et al., 2005). Inevitably 
Malaysia is just another country that has to deal with this global burden; a lot of studies 
have been carried out in Malaysia related to that of drug abuse and addiction. 
Simultaneously Malaysian anti narcotics taskforce is progressively working on the 
preventive and control measures of narcotics abuse (Deva, M.P, 1977).  
 
Malaysia has the fastest growing economies in South East Asia with a population of 
approximately 26 million; experiencing extreme problems associated with the use of 
illicit drugs, there were 235495 registered drug users and offenders are registered in 
between 1988 to2002. Similarly, heroin accounts for 63% of drug abuse treatment 
admissions and 69% of drug related criminal offenses in Malaysia (National Drug 
Information (NADI), 2005).  
 
The NADI showed that total number of addicts up to the March 2000 was about 36,350 
persons, 17,373 were new respondents while the remaining 18,977 were the relapsed 
cases (NADI). Governmental anti- narcotic taskforce indicated that 275,499 heroin 
addicts were registered in 2004. WHO estimates that only one of four drug addicts are 
registered. Anti narcotic taskforce revealed that out of the 10,473 cases recorded from 
January to March 2005, 46.2% were new respondents and the remaining 53.8% were 
recidivist cases. Malaysian government is currently spending more than RM50mil per 
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year for drug rehabilitation centre alone. The most frequently abused drugs were heroin 
(36%), morphine (30%), cannabis (23%) and metamphetamine (7%). 
In 1995, the total number of inmates in all prison institutions in Malaysia was 21,513. 
Out of this figure, 8,513  (39.57 %) were inmates allied with drug related offences 
furthermore, in 1996 Prison Statistics report illustrated that the total number of prisoners 
on remand and convicted as drug traffickers and abusers was high compared to that of the 
previous years. Out of 8,291 prisoners, 4,245 (50 %) were abusers of illegal drugs, and 
1,204 (46 %) were drug traffickers (Malaysian Prison Statistics, 1996). 
  
 
 
 
 
 
 
 
 
Figure 1.7: Total number of drug addicts in Malaysia (1988-1998) 
Source: Anti-narcotic taskforce, time series Report (1988-1998)  
1.5.2.1 Distribution  
Retrospective study and typological characteristics of the different type of the addicts 
showed that there are different types of drug addiction, which are mainly categorized 
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accordingly to the involvement in drug addiction, starting from low involvement (Type I) 
to very high involvement (Type VI) (Table 1.5). 
Table 1.5 Drug Addiction Classifications 
No Type of Addiction Involvement and illustration 
01 Type I 3 years Devoted to addiction. 
02  Type II 4 years Devoted to addiction (largest time 
incarcerated) 
03 Type III & IV 6 years Devoted to addiction 
04 Type V 8 years Devoted to addiction 
05 Type VI 9 years Devoted to addiction (shortest time 
incarcerated) 
Source: Research Report No. 25, 1990 
 
Drug abuse is a source of social ill like suicides, accidents, prostitution, school/work 
absenteeism, delinquency, family violence, overall loss of responsiveness and initiative, 
narcotic production and drug trafficking progressively lead to corruption, criminal 
activities, violence and intimidation (Anti Narcotic Task Force, 1990).  
Teenagers knew the ways of abusing drugs by different way of administration. They 
obtained information about drugs via the mass media, social clubs, rehabilitation centers 
and school. Study by Low, W. Y., (1996) acknowledged that both the parents and 
teenagers are ignorant to the long term effects of abusing drugs. 
 The factors which influence drug-taking behavior are complex and multifaceted which 
include; Personal, social, economic, family, environmental and physiological (Deva, M.P, 
1977).  
